Exscientia Plc - ADR

NASDAQ:EXAI  
19.54
-1.69 (-7.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.15B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.01 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$20.43
50-Day MAN/A
200-Day MAN/A
See more pivots

Exscientia Plc - ADR Stock, NASDAQ:EXAI

The Schr?¶dinger Building Oxford, Oxford, Oxfordshire OX4 4GE
United Kingdom
Phone: +44.1865.818941
Number of Employees:

Description

Exscientia Plc operates as an AI-driven pharmatech company which is engaged in designing and developing patient-based drugs. The firm has designed three drugs that are in phase 1 human clinical trials. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.